Cash flow generation remains erratic and disconnected from earnings, highlighted by a 2026Q1 OCF/NI ratio of 0.02 and a free cash flow deficit of $6.4 million.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Cash from Operations | 17.85M | -9.06M | 18.22M | 36.44M | 205.81M | 122.24M | 44.72M | 42.22M | 156.24M | 10.83M | 67.36M | 15.65M | -3.8M | 6.66M | 11.96M | 10.15M | 899K | -21.85M | -41.28M | -31.67M | -9.22M | -2.14M | -18.6M | -14.02M |
| Operating CF Margin % | - | -1.2% | 2.29% | 4.66% | 27.39% | 19.78% | 8.93% | 9.46% | 41.62% | 4.2% | 40.95% | 12.26% | -4.24% | 7.75% | 13.7% | 12.66% | 1.63% | -51.2% | -104.2% | -96.31% | -13.7% | -3.33% | -960.46% | -392.42% |
| Operating CF Growth % | -36.22% | -149.75% | -50% | -82.29% | 68.37% | 173.33% | 5.93% | -72.98% | 1342.93% | -83.93% | 330.39% | 512.19% | -157.04% | -44.33% | 17.85% | 1028.59% | 104.11% | 47.06% | -30.33% | -243.33% | -331.68% | 88.51% | -32.64% | - |
| Net Income | -196.02M | -99.43M | -196.08M | -83.91M | -175.66M | 215.51M | 6.25M | 37.31M | 84.06M | 24M | 26.84M | 16.52M | -6.98M | -25.43M | 2.48M | 6.65M | 2.98M | -45.5M | -78.29M | -11.16M | -36.3M | -31.21M | -29.46M | -33.25M |
| Depreciation & Amortization | 49.53M | 95.55M | 101.62M | 92.98M | 83.2M | 67.61M | 56.06M | 48.8M | 31.29M | 20.77M | 11.89M | 11.94M | 8.54M | 9.16M | 8.82M | 6.61M | 5.51M | 4.78M | 5.13M | 8.94M | 9.61M | 16.4M | 2.14M | 2.03M |
| Stock-Based Compensation | 0 | 0 | 5.04M | 9.63M | 9.92M | 7.8M | 5.29M | 3.65M | 4.25M | 2.92M | 3.98M | 3.97M | 1.5M | 1.25M | 1.51M | 0 | 0 | 960K | 1.68M | 1.02M | 1.13M | 749K | 0 | 0 |
| Deferred Taxes | 0 | 14.11M | 2.1M | 3.32M | 21.7M | 5.07M | 7.49M | 6.74M | -26.12M | -6.14M | -1.75M | -6.67M | -39K | 1.49M | -8.29M | 0 | 0 | 16.36M | 24.03M | 0 | 3.83M | 12.05M | 0 | 0 |
| Other Non-Cash Items | 119.85M | 39.11M | 173.75M | 24.37M | 161.37M | -171.47M | 6.51M | 14.61M | -9.17M | 4.97M | 7.16M | -13.61M | 12.07M | 26.89M | 4.9M | -1.41M | -3.32M | 2.76M | 7.89M | -33.84M | 4.71M | 207K | 4.5M | 16.83M |
| Working Capital Changes | 44.49M | -58.4M | -68.21M | -9.94M | 105.28M | -2.28M | -36.87M | -68.9M | 71.93M | -35.68M | 19.23M | 3.49M | -18.88M | -6.71M | 2.54M | -1.71M | -4.27M | -1.21M | -1.72M | 3.36M | 7.8M | -329K | 4.23M | 365.25K |
| Change in Receivables | 0 | -27.6M | 0 | 0 | -53.68M | -48.03M | -4.18M | -49.33M | -1.85M | -7.88M | -4.11M | 4.42M | -9.26M | -2.48M | -4.68M | 0 | -6.55M | -2.2M | 7.43M | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | -9.18M | 0 | 0 | -4.41M | -11.65M | -3.63M | -1.36M | -283K | 814K | -360K | -5K | -916K | 60K | 831K | -1.1M | -710K | -249K | -146K | 1.78M | -137K | -1.15M | 0 | 0 |
| Change in Payables | 0 | -7.02M | 0 | 0 | 24.55M | 31.34M | 2.17M | -2.03M | 5.01M | 1.9M | -1.3M | -8.81M | 2.42M | 218K | -3.85M | 0 | 1.52M | -2.19M | -9.63M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 169.6M | 159.86M | -71.19M | -13.29M | -412.8M | -243.85M | -155.09M | -86.63M | -39.13M | -269.03M | -5.97M | -23.42M | 2.98M | -31.51M | 5.78M | -15.07M | -9.88M | -2.08M | 61.05M | 21.3M | 19.37M | 12.37M | -31.04M | -21.5M |
| Capital Expenditures | -65.93M | -79.36M | -117.47M | -213.32M | -181.35M | -118.94M | -99.07M | -31.32M | -27.87M | -17.59M | -10.15M | -11.5M | -5.28M | -5.19M | -10.18M | -8.14M | -2.43M | -2.21M | -3.51M | -4.35M | -2.56M | -4.14M | 0 | 0 |
| CapEx % of Revenue | 8.85% | 10.48% | 14.74% | 27.3% | 24.13% | 19.25% | 19.78% | 7.02% | 7.42% | 6.83% | 6.17% | 9% | 5.9% | 6.04% | 11.66% | 10.16% | 4.4% | 5.18% | 8.87% | 13.22% | 3.79% | 6.46% | - | - |
| Acquisitions | 210.64M | 213.76M | 42.78M | -20.16M | -83.82M | -21.09M | -33.63M | -52.15M | 5.17M | -270.32M | -43.44M | 37.11M | -2.44M | -1.03M | -3M | 0 | 1.2M | 157K | 8.52M | 42.74M | 0 | -366K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 23.33M | 0 | -2.78M | 8.22M | 3.03M | -7.38M | -6.24M | -583K | -2.14M | 691K | 44.45M | -49.39M | 1.07M | 583K | 46K | 562K | 1K | 320K | 2.05M | 332K | 19K | 19.99M | 31.04M | 21.39M |
| Cash from Financing | -89.88M | -30.93M | -161.42M | 71.96M | -58.15M | 398.43M | 246.41M | 211.26M | -77.76M | 240.72M | -19.67M | 2.49M | 3.1M | 31.94M | 2.6M | 2.14M | -3.37M | 1.52M | -4.31M | -1M | 16.11M | 25.94M | 54.06M | 34.8M |
| Debt Issued (Net) | -34.24M | -6.96M | -152.07M | 84.6M | -53.11M | 14.77M | -5.16M | 209.36M | -79.34M | 148.37M | -19.72M | 1.07M | 4.25M | -184K | 1.9M | 3.61M | -3.49M | 1.29M | -1.73M | 23K | -1.85M | -2.52M | 0 | 0 |
| Equity Issued (Net) | -1.38M | -1.27M | 0 | 0 | 355K | 404.32M | 249.97M | 0 | 0 | 90.25M | 0 | 1.97M | 0 | 30.03M | -113K | -67K | 123K | 234K | 0 | 88K | 18.68M | 28.46M | 53.17M | 36.13M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -551K | -1.81M | -278K | 0 | 0 | -383K | -4.06M | 0 | -6.04M | -7.44M | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -109K | -113K | -67K | -96K | -44K | 0 | -59K | -83K | 0 | 0 | 0 |
| Other Financing | -54.26M | -22.71M | -9.35M | -12.63M | -5.39M | -20.66M | 1.59M | 1.9M | 1.58M | 2.11M | 53K | -551K | -1.16M | 2.09M | -2.19M | -1.4M | 0 | 0 | -2.58M | -1.11M | -727K | 0 | 885.22K | -1.33M |
| Net Change in Cash | 99.46M | 148.32M | -204.52M | 95.75M | -284.17M | 276.75M | 145.55M | 167.98M | 42.04M | -16.92M | 39.44M | -4.21M | 3.07M | 6.58M | 21.29M | -3.31M | -11.84M | -22.14M | 17.07M | -20.2M | 26.54M | 37.27M | 2.82M | -2.32M |
| Free Cash Flow | -44.92M | -78.74M | -114.02M | -179.56M | 24.46M | 3.29M | -54.35M | 10.31M | 128.37M | -6.76M | 57.21M | 4.16M | -9.08M | 1.47M | 1.78M | 2.01M | -1.53M | -24.07M | -44.79M | -36.02M | -11.78M | -6.28M | -18.6M | -14.02M |
| FCF Margin % | -6.03% | -10.4% | -14.31% | -22.98% | 3.25% | 0.53% | -10.85% | 2.31% | 34.2% | -2.62% | 34.78% | 3.25% | -10.14% | 1.71% | 2.04% | 2.5% | -2.78% | -56.38% | -113.07% | -109.54% | -17.49% | -9.8% | -960.46% | -392.42% |
| FCF Growth % | 49.55% | 30.94% | 36.5% | -834.18% | 642.47% | 106.06% | -627.12% | -91.97% | 1999.29% | -111.81% | 1276.92% | 145.76% | -718.88% | -17.68% | -11.21% | 230.83% | 93.63% | 46.27% | -24.35% | -205.75% | -87.57% | 66.23% | -32.64% | - |
| FCF per Share | -0.13 | -0.22 | -0.32 | -0.51 | 0.07 | 0.01 | -0.18 | 0.03 | 0.44 | -0.02 | 0.22 | 0.02 | -0.03 | 0.01 | 0.01 | 0.01 | -0.01 | -0.11 | -0.24 | -0.25 | -0.20 | -0.12 | -0.43 | -7.80 |
| FCF Conversion (FCF/Net Income) | 0.23x | 0.09x | -0.09x | -0.43x | -1.17x | 0.57x | 7.12x | 1.11x | 1.86x | 0.45x | 2.45x | 0.95x | 0.54x | -0.26x | 4.83x | 1.50x | 0.28x | 0.48x | 0.53x | 2.84x | 0.28x | 0.06x | 0.63x | 0.42x |
| Interest Paid | 943K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High cash burn volatility
As reported in financial statements, Evotec's operating cash flow frequently diverges from net income, with the 2026Q1 OCF/NI ratio of 0.02 highlighting a persistent inability to convert accounting losses into meaningful cash generation, suggesting that the company's reported earnings are heavily influenced by non-cash accounting adjustments.
The consistent gap between net income and operating cash flow indicates that the company's core operations are not yet self-funding. Investors should monitor whether this disconnect is driven by aggressive revenue recognition or the timing of milestone payments, as the current trend suggests that cash generation remains decoupled from operational performance.
Based on recent quarterly data, Evotec's free cash flow trajectory remains erratic, swinging from a peak of $49.1M in 2024Q4 to a deficit of $6.4M in 2026Q1, which underscores the inherent instability of a business model reliant on lumpy, project-based milestone payments rather than recurring revenue.
The inability to maintain positive free cash flow suggests that the company's high fixed-cost base is not being adequately covered by its current service volume. This volatility may indicate that the company is struggling to achieve the scale necessary to transition from a cash-burning growth phase to a self-sustaining operational model.
According to historical filings, Evotec's capital expenditure as a percentage of revenue reached as high as 31.5% in 2023Q4, reflecting the heavy investment required to maintain its J.POD biologics manufacturing facilities, which continues to exert significant pressure on the company's overall cash position and liquidity profile.
The high capital intensity suggests that the company is locked into a cycle of continuous reinvestment to maintain its technological edge. If these investments do not yield a commensurate increase in high-margin royalty income, the company may face ongoing challenges in achieving a sustainable return on its invested capital.
As evidenced by the $72.7M working capital inflow in 2026Q1, Evotec's cash flow is frequently bolstered by volatile changes in working capital, which often obscures the underlying operational cash burn and makes it difficult to assess the true efficiency of the company's collection and payment cycles.
The reliance on working capital fluctuations to manage liquidity suggests that the company's cash management is highly sensitive to the timing of client payments and milestone receipts. Investors should be cautious, as these inflows are often temporary and do not represent a permanent improvement in the company's fundamental cash-generating capability.
Based on reported figures, Evotec has directed its limited capital toward facility expansion and strategic acquisitions rather than shareholder returns, with minimal dividend or buyback activity observed, indicating that management remains focused on scaling the platform despite the ongoing pressure on the company's cash reserves.
The lack of shareholder-friendly capital allocation is consistent with a company in a high-growth, capital-intensive phase. However, given the persistent negative operating margins, this strategy warrants further investigation into whether the expected returns on these investments will be sufficient to justify the continued dilution or debt accumulation risks.
Quick answers to the most common questions about buying EVO stock.
Evotec SE (EVO) generated $-9.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Evotec SE (EVO) reported negative free cash flow of $78.7M in 2025, indicating capital requirements exceeded cash from operations.
Evotec SE (EVO) spent $79.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.